On first reading, when I saw " preparing to evaluate the effectiveness of our Electroceutical™ Therapy" I thought the were preparing to start the studies but backing up to the opening of that section they stated, "We are currently conducting several pre- clinical studies to assess the effectiveness of our Electroceutical Therapy in animal models of critical limb ischemia (CLI), non-alcoholic steatohepatitis (NASH) and renal inflammation."
After looking at both I would say the studies are rapping up and they are getting the data together.
They went on and on about the kidney, must have some strong preliminary data. On of the things I liked most was when they stated "We believe seeking commercial partnerships with several of the largest providers of dialysis may allow our Electroceutical™ Therapy to achieve high market penetration and adoption."
That's what they are going to need to do with so many targeted applications here, IMO. Get some backing! Make a deal to share the profits for pushing this though the regulatory process and get it to market!
News 
Market Data 
Discover 
